Capricor Therapeutics CAPR Return on invested capital

Return on invested capital at other companies

PfizerPFE

6%—

Celldex TherapeuticsCLDX

-49.8%+49.0pp

Dyne Therapeutics, Inc.DYN

-188.2%+14.8pp

Edgewise Therapeutics, Inc.EWTX

-47.1%+14.7pp

Sutro BiopharmaSTRO

-142.7%-273pp

MaxCyteMXCT

-25%+0.5pp

FAQ

What is Capricor Therapeutics's return on invested capital?

Capricor Therapeutics (CAPR) reported return on invested capital of -83.2% in Q1 2026.

How has Capricor Therapeutics's return on invested capital changed year-over-year?

Capricor Therapeutics's return on invested capital increased by 14.5% year-over-year, from -97.3% to -83.2%.

What is the long-term trend for Capricor Therapeutics's return on invested capital?

Over 3 years (2022 to 2025), Capricor Therapeutics's return on invested capital has grown at a -39.0% compound annual growth rate (CAGR), from -566.3% to -128.7%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.